Delivery Order SPE2DP20D0002-SPE2DP25F054T
Award Date 8/12/25
Potential Completion Date 8/26/25
Potential Value $330K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Teva Pharmaceuticals USA, Inc. has been awarded a $1,526,969 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4 vaccine. This delivery order was issued under an existing contract vehicle and will support the immunization programs of the military. Teva will deliver the vaccine products to the agency's location in Parsippany, New Jersey by December 19, 2023. As a major pharmaceutical manufacturer, Teva has extensive experience...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $660,627.72 to Teva Pharmaceuticals USA, Inc. for Adenovirus Type 4 vaccine on August 12, 2025, with an ultimate completion date of August 26, 2025. This firm-fixed-price delivery order, issued without set-aside designation, represents continued federal procurement from Teva as a critical supplier of vaccines and pharmaceutical products to military immunization programs. The contract will be performed at...
- Teva Pharmaceuticals USA, Inc. has been awarded a $305,393.76 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to provide adenovirus type 4 vaccine. Performance will take place in Parsippany, New Jersey through December 2023. This delivery order was issued against an existing contract vehicle and supports the immunization programs of the military. Teva Pharmaceuticals has a history of partnering with subcontractors and receiving contract awards to supply...
- Teva Pharmaceuticals USA, Inc. has been awarded a $916,181 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4 vaccine. The delivery order was awarded on December 14, 2023 and is to be completed by December 19, 2023. Teva will provide the vaccine from its Parsippany, New Jersey location to support immunization programs of the Defense Logistics Agency Troop Support Medical. As the prime contractor, Teva has extensive experience...
- The U.S. Department of Defense's Medical Supply Chain division awarded a $1.16M firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc. for Adenovirus Type 4 vaccine, with an ultimate completion date of August 26, 2025. The contract, which carries no set-aside designation, will be performed at Teva's manufacturing facility in Parsippany, New Jersey. This delivery order represents a continuation of Teva's established role as a critical supplier of vaccines and pharmaceutical products to...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the provision of Adenovirus Type 4 vaccine. The contract has a ceiling value of $317,609.46 and a performance period through August 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) vehicle held by Teva with the DLA, under which the company serves as a prime vendor for...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract has a ceiling value of $317,609.46 and a period of performance through November 19, 2024. The award is unrestricted, meaning Teva competed as a large business without any set-aside designations. Teva is a major pharmaceutical supplier to federal...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract has a ceiling value of $165,156.93 and a period of performance through March 25, 2025. Teva is a major pharmaceutical supplier to federal agencies, providing critical medical products including vaccines, antiviral medications, respiratory...
- This is a firm fixed-price delivery order awarded to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) Troop Support Medical. The $158,804.73 contract is for the supply of Adenovirus Type 4 vaccines, with a performance period running through June 25, 2024. Teva Pharmaceuticals USA, Inc. is not designated under any set-aside program for this award. This delivery order is part of Teva's broader role as a prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccine. The $271,494.00 firm fixed price delivery order does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a pharmaceutical manufacturer that has provided a range of drug products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to federal customers such as...